389 related articles for article (PubMed ID: 27438851)
1. Curcumin AntiCancer Studies in Pancreatic Cancer.
Bimonte S; Barbieri A; Leongito M; Piccirillo M; Giudice A; Pivonello C; de Angelis C; Granata V; Palaia R; Izzo F
Nutrients; 2016 Jul; 8(7):. PubMed ID: 27438851
[TBL] [Abstract][Full Text] [Related]
2. The beneficial role of curcumin on inflammation, diabetes and neurodegenerative disease: A recent update.
Ghosh S; Banerjee S; Sil PC
Food Chem Toxicol; 2015 Sep; 83():111-24. PubMed ID: 26066364
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic applications of curcumin for patients with pancreatic cancer.
Kanai M
World J Gastroenterol; 2014 Jul; 20(28):9384-91. PubMed ID: 25071333
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo anticancer efficacy of silibinin against human pancreatic cancer BxPC-3 and PANC-1 cells.
Nambiar D; Prajapati V; Agarwal R; Singh RP
Cancer Lett; 2013 Jun; 334(1):109-17. PubMed ID: 23022268
[TBL] [Abstract][Full Text] [Related]
5. Long-Circulating Curcumin-Loaded Liposome Formulations with High Incorporation Efficiency, Stability and Anticancer Activity towards Pancreatic Adenocarcinoma Cell Lines In Vitro.
Mahmud M; Piwoni A; Filipczak N; Janicka M; Gubernator J
PLoS One; 2016; 11(12):e0167787. PubMed ID: 27936114
[TBL] [Abstract][Full Text] [Related]
6. Biological and pharmacological evaluation of dimethoxycurcumin: A metabolically stable curcumin analogue with a promising therapeutic potential.
Teymouri M; Barati N; Pirro M; Sahebkar A
J Cell Physiol; 2018 Jan; 233(1):124-140. PubMed ID: 27996095
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of liposomal curcumin in a human pancreatic tumor xenograft model: inhibition of tumor growth and angiogenesis.
Ranjan AP; Mukerjee A; Helson L; Gupta R; Vishwanatha JK
Anticancer Res; 2013 Sep; 33(9):3603-9. PubMed ID: 24023285
[TBL] [Abstract][Full Text] [Related]
8. Mechanistic Understanding of Curcumin's Therapeutic Effects in Lung Cancer.
Wan Mohd Tajuddin WNB; Lajis NH; Abas F; Othman I; Naidu R
Nutrients; 2019 Dec; 11(12):. PubMed ID: 31817718
[TBL] [Abstract][Full Text] [Related]
9. Anti-Angiogenic Activity of Curcumin in Cancer Therapy: A Narrative Review.
Shakeri A; Ward N; Panahi Y; Sahebkar A
Curr Vasc Pharmacol; 2019; 17(3):262-269. PubMed ID: 29424316
[TBL] [Abstract][Full Text] [Related]
10. Long term effect of curcumin in regulation of glycolytic pathway and angiogenesis via modulation of stress activated genes in prevention of cancer.
Das L; Vinayak M
PLoS One; 2014; 9(6):e99583. PubMed ID: 24932681
[TBL] [Abstract][Full Text] [Related]
11. Curcumin as an anti-cancer agent: review of the gap between basic and clinical applications.
Bar-Sela G; Epelbaum R; Schaffer M
Curr Med Chem; 2010; 17(3):190-7. PubMed ID: 20214562
[TBL] [Abstract][Full Text] [Related]
12. Latest in Vitro and in Vivo Assay, Clinical Trials and Patents in Cancer Treatment using Curcumin: A Literature Review.
Doello K; Ortiz R; Alvarez PJ; Melguizo C; Cabeza L; Prados J
Nutr Cancer; 2018; 70(4):569-578. PubMed ID: 29708445
[TBL] [Abstract][Full Text] [Related]
13. Curcumin therapeutic promises and bioavailability in colorectal cancer.
Shehzad A; Khan S; Shehzad O; Lee YS
Drugs Today (Barc); 2010 Jul; 46(7):523-32. PubMed ID: 20683505
[TBL] [Abstract][Full Text] [Related]
14. Mitochondria as a target in the therapeutic properties of curcumin.
Trujillo J; Granados-Castro LF; Zazueta C; Andérica-Romero AC; Chirino YI; Pedraza-Chaverrí J
Arch Pharm (Weinheim); 2014 Dec; 347(12):873-84. PubMed ID: 25243820
[TBL] [Abstract][Full Text] [Related]
15. Potentiation of paclitaxel activity by curcumin in human breast cancer cell by modulating apoptosis and inhibiting EGFR signaling.
Zhan Y; Chen Y; Liu R; Zhang H; Zhang Y
Arch Pharm Res; 2014 Aug; 37(8):1086-95. PubMed ID: 24318305
[TBL] [Abstract][Full Text] [Related]
16. Curcumin Induces Pancreatic Adenocarcinoma Cell Death Via Reduction of the Inhibitors of Apoptosis.
Díaz Osterman CJ; Gonda A; Stiff T; Sigaran U; Valenzuela MM; Ferguson Bennit HR; Moyron RB; Khan S; Wall NR
Pancreas; 2016 Jan; 45(1):101-9. PubMed ID: 26348467
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effects of curcumin on gastric cancer cells: a proteomic study of molecular targets.
Cai XZ; Huang WY; Qiao Y; Du SY; Chen Y; Chen D; Yu S; Che RC; Liu N; Jiang Y
Phytomedicine; 2013 Apr; 20(6):495-505. PubMed ID: 23351961
[TBL] [Abstract][Full Text] [Related]
18. Multiple biological activities of curcumin: a short review.
Maheshwari RK; Singh AK; Gaddipati J; Srimal RC
Life Sci; 2006 Mar; 78(18):2081-7. PubMed ID: 16413584
[TBL] [Abstract][Full Text] [Related]
19. Antitumor Effects of 10058-F4 and Curcumin in Combination Therapy for Pancreatic Cancer In Vitro and In Vivo.
Jie Z; Jinna Z; Jingjun Z; Pengcheng L; Fang Y; Qinyang C; Taiyu C; Hequn J; Tao R
J Healthc Eng; 2022; 2022():1620802. PubMed ID: 35368919
[TBL] [Abstract][Full Text] [Related]
20. Curcumin inhibits tumor growth and angiogenesis in glioblastoma xenografts.
Perry MC; Demeule M; Régina A; Moumdjian R; Béliveau R
Mol Nutr Food Res; 2010 Aug; 54(8):1192-201. PubMed ID: 20087857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
